Perceptive Advisors LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $3 Billion distributed in 99 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Verona Pharma PLC with a value of $297M, Arcellx, Inc. with a value of $265M, Amicus Therapeutics, Inc. with a value of $228M, Rhythm Pharmaceuticals, Inc. with a value of $206M, and Nuvalent, Inc. with a value of $205M.

Examining the 13F form we can see an decrease of $830M in the current position value, from $3.83B to 3B.

Perceptive Advisors LLC is based out at New York, NY

Below you can find more details about Perceptive Advisors LLC portfolio as well as his latest detailed transactions.

Portfolio value $3 Billion
Healthcare: $3 Billion

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 99
  • Current Value $3 Billion
  • Prior Value $3.83 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 21 stocks
  • Additional Purchases 12 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 43 stocks
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.